Squadron Capital Management LLC - 24 Feb 2026 SCHEDULE 13G Report for Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL)

Filing Manager
Squadron Capital Management LLC
Reporting Manager
Squadron Master Fund LP
Security
Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share
Symbol
ZNTL
Shares outstanding
72,096,078 shares
Disclosed Ownership
3,676,900 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
03 Mar 2026, 16:05:37 UTC
Date of event
24 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squadron Master Fund LP 5.1% 3,676,900 0 3,676,900 /s/ Matthew Sesterhenn Partner, Squadron Partners LLC, its General Partner
Squadron Capital Management LLC 5.1% 3,676,900 0 3,676,900 /s/ Matthew Sesterhenn Partner
Matthew Sesterhenn 5.1% 3,676,900 0 3,676,900 /s/ Matthew Sesterhenn Matthew Sesterhenn
William Blank 5.1% 3,676,900 0 3,676,900 /s/ William Blank William Blank